Acute chest pain (ACP) is a common presenting symptom in clinical practice, often posing a diagnostic challenge for clinicians. It is crucial to promptly identify its cause, as it may be a manifestation of life-threatening conditions such as acute coronary syndrome (ACS).
Initial evaluation should include a thorough history and physical examination. The clinician should assess the patient's risk factors for coronary artery disease (CAD), the characteristics of the pain, and accompanying symptoms. Electrocardiogram (ECG) and cardiac biomarkers are essential in the early detection of myocardial ischemia.
When initial investigations are inconclusive, diagnostic imaging can provide further insights. Coronary computed tomography angiography (CCTA) is increasingly used in the evaluation of ACP due to its high negative predictive value. However, it should be used judiciously considering its associated radiation exposure.
Clinical decision rules such as the HEART score can guide clinicians in risk stratification and decision-making. These tools incorporate elements of history, ECG findings, age, risk factors, and troponin levels to predict the likelihood of major adverse cardiac events.
The management of ACP is guided by its underlying cause. In cases of suspected ACS, immediate reperfusion therapy is indicated. For non-cardiac chest pain, appropriate management includes symptom control and addressing the underlying cause.
In conclusion, the evaluation of ACP requires a systematic approach, incorporating clinical history, physical examination, diagnostic investigations, and risk stratification tools. Prompt identification and management of the underlying cause are essential to improve patient outcomes. As clinicians, maintaining a high index of suspicion and utilizing available diagnostic tools judiciously can aid in deciphering the enigma of acute chest pain.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation